(株)ＪＣＬバイオアッセイの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証JQS | サービス業 | 2190/E22551 | JCL Bioassay Corporation |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2013/06/21 | 日証協 | 95,200株 | 0% | 1,200株 | -29.41% | 65,821株 | -1.05% | 600株 | -89.29% |
| 2013/06/14 | 日証協 | 95,200株 | +1.28% | 1,700株 | -91.83% | 66,521株 | +6.4% | 5,600株 | -16.42% |
| 2013/06/07 | 日証協 | 94,000株 | +14.91% | 20,800株 | -39.36% | 62,521株 | +11.6% | 6,700株 | -51.45% |
| 2013/05/31 | 日証協 | 81,800株 | +3.28% | 34,300株 | +75.9% | 56,021株 | +0.54% | 13,800株 | +176% |
| 2013/05/24 | 日証協 | 79,200株 | -15.11% | 19,500株 | +119.1% | 55,721株 | -20.29% | 5,000株 | -80.95% |
| 2013/05/17 | 日証協 | 93,300株 | +3.32% | 8,900株 | +1012.5% | 69,901株 | +28.25% | 26,250株 | +510.47% |
| 2013/05/10 | 日証協 | 90,300株 | +1.01% | 800株 | -87.1% | 54,502株 | -5.38% | 4,300株 | -23.21% |
| 2013/05/02 | 日証協 | 89,400株 | -9.61% | 6,200株 | -81.04% | 57,603株 | -8.72% | 5,600株 | -39.13% |
| 2013/04/26 | 日証協 | 98,900株 | +4.55% | 32,700株 | +29.76% | 63,103株 | +3.61% | 9,200株 | -48.31% |
| 2013/04/19 | 日証協 | 94,600株 | +33.43% | 25,200株 | +1475% | 60,903株 | +7.03% | 17,800株 | +134.21% |
| 2013/04/12 | 日証協 | 70,900株 | +5.11% | 1,600株 | -81.5% | 56,903株 | +14.49% | 7,600株 | +55.1% |
| 2013/04/05 | 日証協 | 67,450株 | +44.28% | 8,650株 | -85.05% | 49,703株 | -4.23% | 4,900株 | -87.44% |
| 2013/03/29 | 日証協 | 46,750株 | +328.9% | 57,850株 | +796.9% | 51,900株 | +308.56% | 39,003株 | +729.85% |
| 2013/03/22 | 日証協 | 10,900株 | +1.87% | 6,450株 | -28.33% | 12,703株 | -3.05% | 4,700株 | -48.35% |
| 2013/03/15 | 日証協 | 10,700株 | +59.53% | 9,000株 | +210.34% | 13,103株 | +8.26% | 9,100株 | +152.29% |
| 2013/03/08 | 日証協 | 6,707株 | -53.42% | 2,900株 | -69.81% | 12,103株 | -39.19% | 3,607株 | -60.36% |
| 2013/03/01 | 日証協 | 14,400株 | +118.18% | 9,607株 | 0% | 19,903株 | +40.13% | 9,100株 | +28.17% |
| 2013/02/22 | 日証協 | 6,600株 | 0% | 0株 | -100% | 14,203株 | +10.08% | 7,100株 | +273.68% |
| 2013/02/15 | 日証協 | 6,600株 | -31.96% | 3,100株 | +933.33% | 12,903株 | -42.15% | 1,900株 | -58.7% |
※株式分割は考慮していませんのでご注意ください。
Page Top